Initial experiences with Corevalve® for transcatheter aortic valve implantation in Turkey: two case reports

Oğuz Yılmaz,

doi:10.5606/tgkdc.dergisi.2013.6167

Oğuz Yılmaz¹, Bingür Sönmez¹, Servet Öztürk², Harun Arbatlı⁴, Deniz Şener², Türker Baran², Ekrem Selçukoğlu³

¹Department of Cardiovascular Surgery, Şişli Memorial Hospital, İstanbul, Turkey
²Department of Cardiology, Şişli Memorial Hospital, İstanbul, Turkey
³Department of Anaesthesiology and Reanimation, Şişli Memorial Hospital, İstanbul, Turkey
⁴Department of Cardiovascular Surgery, Maltepe University Hospital, İstanbul, Turkey

DOI : 10.5606/tgkdc.dergisi.2013.6167

Transcatheter aortic valve implantation (TAVI) has become an alternative treatment modality in patients with severe aortic stenosis who are not candidates for open surgery. We performed two of the initial procedures in our center with the CoreValve® Revalving System, which has been recently introduced to the market. In this article, we report the outcomes of this procedure after a nine-month followup and discuss the different aspects of the two prostheses commercially available in Turkey.

Keywords : Aortic stenosis; percutaneous catheter; transcatheter aortic valve implantation

Viewed : 9642

Downloaded : 2091